86620-62-4

Usage

Uses

Used in Chemical Manufacturing:
4-(4-Methylpiperazino)benzoic acid is used as an intermediate in the synthesis of various chemical compounds for different applications, leveraging its unique structure and reactivity.
Used in Pharmaceutical Industry:
4-(4-Methylpiperazino)benzoic acid is used as a building block in the development of pharmaceuticals, potentially contributing to the creation of new drugs with specific therapeutic properties due to its distinct chemical structure.
Used in Research and Development:
4-(4-Methylpiperazino)benzoic acid serves as a research compound for studying its chemical properties, reactivity, and potential interactions with other molecules, which can lead to the discovery of new applications and uses in various industries.

InChI:InChI=1/C12H16N2O2.ClH/c1-13-6-8-14(9-7-13)11-4-2-10(3-5-11)12(15)16;/h2-5H,6-9H2,1H3,(H,15,16);1H

Upstream product

• 109-01-3 1-methyl-piperazine 
• 619-42-1 4-methoxycarbonylphenyl bromide 

Downstream Products

• 1055925-62-6 N'-(2-cyano-9-methyl-9H-purin-6-yl)-N'-cyclopentyl-4-(4-methyl-1-piperazinyl)benzohydrazide trifluoroacetate 
• 1055925-61-5 N'-(2-cyano-9-methyl-9H-purin-6-yl)-N'-cyclopentyl-4-(4-methyl-1-piperazinyl)benzohydrazide 
• 1616960-86-1 N-(2-(2-methyl-1H-indol-1-yl)ethyl)-4-(4-methylpiperazin-1-yl)benzamide 
• 1616961-23-9 N-(2-(2-methyl-1H-indol-3-yl)ethyl)-4-(4-methylpiperazin-1-yl)benzamide 

Relevant academic research and scientific papers

C-3 NOVEL TRITERPENONE WITH C-17 REVERSE AMIDE DERIVATIVES AS HIV INHIBITORS

The present invention relates to C-3 novel triterpenone with C-17 reverse amide compounds of Formula (I); and pharmaceutically acceptable salts thereof, wherein ring Formula (II), R1, R2, R3, R4, R5, R6, R7, 'n' and 'm' are as defined in Formula (I). The invention also relates to C-3 novel triterpenone with C-17 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Benzamide nitriles

Compounds of the formula (I) wherein m, n, A, R1, R2, R3, R4, R5 and R6 are as described herein, together with methods for making the compounds and using the compounds for treatment of diseases or conditions mediated by Cathepsin K.

Piperazine-substituted aryl and aralkyl carboxylic acids useful for treating infirmaties caused by excess lipids or thrombocyte

The present invention is concerned with new carboxylic acid derivatives, with processes for the preparation thereof and with pharmaceutical compositions for lipid depression and thrombocyte aggregation, containing them, and to methods for treating infirmaties caused by excess lipids or thrombocyte aggregation. The new carboxylic acid derivatives according to the present invention are compounds of the general formula: STR1 wherein A is a valency bond or a lower alkylene chain, B is a valency bond or a saturated or unsaturated lower alkylene chain, R is hydrogen, an alkyl group which can be substituted by hydroxyl, carboxyl, sulphonic acid or optionally substituted phenoxy group, or R is an aralkyl radical, the aryl moiety of which can be substituted and the alkyl moiety of which is optionally unsaturated and can contain up to 4 carbon atoms, or R is a phenacyl radical, the phenyl moiety optionally substituted, or R is an acyl radical derived from aliphatic, araliphatic or aromatic carboxylic or sulphonic acid, or R is an aryl radical optionally substituted with the proviso that when A is a valency bond, R cannot be hydrogen, methyl, ethyl, hydroxyethyl, benzyl or phenyl, and the physiologically acceptable salts, esters and amides thereof.